[BP.07.04] THE SNAP-HT TRIAL

Le résumé fourni par la source

Objective: Hypertensive disorders of pregnancy (HDP) affect one in ten pregnancies. Hypertension may persist postpartum, when complications can occur but blood pressure tends to reduce back to pre-pregnancy levels over 3–6 months. In essential hypertension, the TASMINH2 and TASMIN-SR studies showed that self-management significantly improved blood pressure (BP) compared to usual care. The SNAP-HT study applied a similar rationale to test self-titration of antihypertensives following a hypertensive pregnancy in a feasibility trial.Design and method: Postnatal women, taking antihypertensive medication, were randomly allocated to self-management or standard care and followed up for six months. Self-management entailed daily home BP monitoring. Readings were submitted to a mobile phone-based telemonitoring system that provided automatic feedback and included an individualised medication reduction schedule. The primary outcome was feasibility, with secondary outcomes including BP control and safety. Results: 91/188 (48%) women approached were both eligible and consented to randomisation (45:46 intervention:control). Their mean age was 32y (SD 5), mean body mass index 29 kg/m2 (SD 8), and mean baseline BP (day 1–6 postpartum) 133/86mmHg (SD 14/10 respectively). 75/91 (82%) were white British. Index of Multiple Deprivation scores were available for 88/91: 52/88 (59%) 1st/2nd quintiles, 23/88 (26%) 3rd quintile and 13/88 (15%) 4th/5th quintiles. Follow-up is complete with 82/91 (90%) retention, and 9/91 (10%) withdrawals. Considering complete cases: compliance with the trial was 403/410 (98%) scheduled follow-up visits; 36/40 (90%) participants (intervention group) submitted BP readings on at least alternate days whilst on treatment (NICE recommendation); 1075/1513 (71%) expected daily readings (on treatment) were submitted. Secondary outcome data including blood pressure will be available in early 2017 in time for presentation at the conference. Conclusions: The SNAP-HT trial will provide the first randomised controlled evaluation of BP self-management postpartum. The recruitment (approximately 50% of those approached) and retention rates (90%) suggest expanding this study to a larger scale would be practicable. An early indication of the likely efficacy will be available once analysis is complete and will be presented at the conference.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.